Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2015

Conditions
Cerebral Vasospasm
Interventions
DEVICE

Nautilus NeuroWave

"The Nautilus NeuroWave device will be utilized on subjects with sub-arachnoid hemorrhage that undergo TCD measurements to diagnose Vasospasm. A recording will be obtained using the device each time a TCD measurement is made.~In this intervention, patients are recorded using the Nautilus Neurowave device."

DEVICE

Transcranial Doppler (TCD)

Subjects with sub-arachnoid hemorrhage undergo TCD measurements to diagnose Vasospasm. Patients that were detected to have a vasospasm using TCD will also be classified as having mild, moderate and severe vasospasm.

Trial Locations (1)

94142-0114

University of California San Francisco (UCSF), San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Jan Medical, Inc.

INDUSTRY

NCT01595802 - Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm | Biotech Hunter | Biotech Hunter